In particular, CD34+ progenitors from patients with AML, myelodysplatic syndrome (MDS) and CML were shown to express Met at their surface andto produce HGF, thus indicating an autocrine loop of activation of the HGF/Met pathway [18,92,93]. Here, MET is linked to chronic myelogenous leukemia, BCR-ABL1 positive.